Diabetes: How early - and aggressively - to intervene?

Consultant

Volumn 45, Issue 13, 2005, Pages 1416-1420

  Clark, Thomas ^a   Holman, John R ^b,c,d  

^a Space and Naval Warfare Systems Center Pacific   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^d Camp Pendleton Naval Hospital   (United States)

Author keywords

Diabetes; Impaired glucose tolerance; Prevention

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR; METFORMIN; TETRAHYDROLIPSTATIN; TROGLITAZONE;

BODY MASS; CLINICAL TRIAL; DIET RESTRICTION; DISEASE COURSE; EPIDEMIC; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE; LIVER FAILURE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; SCREENING;

EID: 28944442528     PISSN: 00107069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Krakoff J, Lindsay RS, Looker HC, et al. Incidence of retinopathy and nephropathy in youth-onset compared with adult-onset type 2 diabetes. Diabetes Care. 2003;26:76-81.
2. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/diabetes. Accessed September 8, 2005.
3. Boyle JP, Honeycutt AA, Narayan KM, et al. Projection of diabetes through 2050. Diabetes Care. 2001;24:1936-1940.
4. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21: 1414-1431.
5. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med. 1997;(suppl 5):S1-S85.
6. Burke JP, Williams K, Gaskill SP, et al. Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study. Arch Intern Med. 1999;159:1450-1460.
7. Narayan KM, Boyle JP, Thompson TJ, et al. Life-time risk of diabetes mellitus in the United States. JAMA. 2003;290:1884-1890.
8. Hu FB, Stampfer MJ, Haffner SM, et al. Elevated cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care. 2002;25:1129-1134.
9. Chiasson J, Josse RG, Gomis R, et al. Acarbose for the prevention of type 2 diabetes mellitus: the STOP-NIDDM randomized trial. Lancet. 2002; 359:2072-2077.
10. Knowler WC, Barrett-Conner E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
11. Lindstrom J, Louheranta A, Mannelin M, et al. The Finnish diabetes prevention study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care. 2003;26:3230-3236.
12. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and diabetes study. Diabetes Care. 1997;20:537-544.
13. Buchanan TA, Xiang AH, Peters RK, et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes. 2002;51:2796-2803.
14. Torgerson JS, Hauptman J, Holdrin NM, et al. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004;27:155-161.
15. American Diabetes Association. Available at: http://www.diabetes.org. Accessed on September 8, 2005.
16. United States Department of Health and Human Services. Available at http://www.preventiveservices.ahrq.gov. Accessed September 8, 2005.
17. Zhang P, Engelgau E, Valdez R, et al. Cost of screening for pre-diabetes among US adults. Diabetes Care. 2003;26:2536-2542.
18. Nelson RG, Knowler WC, Pettitt DJ, et al. Incidence and determinants of elevated urinary albumin excretion in Pima Indians with NIDDM. Diabetes Care. 1995;18:182-187.
19. Sherwin RS, Anderson RM, Buse JB, et al. Prevention or delay of type 2 diabetes. Diabetes Care. 2003;26:S62-S69.
20. Lorenzo C, Okoloise M, Williams K, et al. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care. 2003;26: 3153-3159.
21. Meigs JB, Williams K, Sullivan LM, et al. Using metabolic syndrome traits for efficient detection of impaired glucose tolerance. Diabetes Care. 2004:27: 1417-1426.
22. D'Agostino RB Jr, Hamman RF, Karter AJ, et al. Cardiovascular disease risk factors predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes Care. 2004;27: 2234-2240.
23. Burke JP, Williams K, Narayan KM, et al. A population perspective on diabetes prevention: whom should we target for preventing weight gain? Diabetes Care. 2003;26:1999-2003.
24. Diabetes Prevention Program Research Group. Effects of withdrawal from metformin on the development of diabetes in the diabetes prevention program. Diabetes Care. 2003;26:977-980.
25. Chiasson JL, Josse RG, Gomis R, et al. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA. 2003;290: 486-494.
26. Ferchak CV, Meneghini LF. Obesity, bariatric surgery and type 2 diabetes-a systematic review. Diabetes Metab Res Rev. 2004;20:438-445.
27. Hu FB, Li TY, Colditz GA, et al. Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA. 2003;289:1785-1791.
28. Chan JM, Rimm EB, Colditz GA, et al. Obesity, fat distribution and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 1994;17: 961-969.
29. van Dam RM, Rimm EB, Willett WC, et al. Dietary patterns and risk of type 2 diabetes mellitus in US men. Ann Intern Med. 2002;136:201-209.
30. Jiang R, Manson JE, Stampfer MJ, et al. Nut and peanut butter consumption and risk of type 2 diabetes in women. JAMA. 2002;288:2554-2560.
31. Schulze MB, Manson JE, Ludwig DS, et al. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA. 2004;292:927-934.
32. Montonen J, Knekt P, Jarvenin R, et al. Whole-grain and fiber intake and the incidence of type 2 diabetes. Am J Clin Nutr. 2003;77:622-629.